About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Kidney Disease Clinical Trials in Los Angeles | 25 Studies

Clinical Trials Kidney DiseaseLos Angeles

Kidney Disease Clinical Trials in Los Angeles

Find 25 clinical trials for kidney disease near Los Angeles, California. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 25 trials

CompletedEfficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaThis is a randomized, double-blind (DB), placebo controlled, crossover study with a two-period, two-sequence (2x2) design evaluating the efficacy and safety of 25 mg QD…NCT06150924·Glendale, Arizona and 43 others

Kidney Disease Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedSmarter Care Virginia, Examining Low-Value Care in VirginiaLow-value care is defined as patient care that provides no net benefit to patients in specific clinical scenarios, and can cause patient harm.NCT04053335·Los Angeles, California

CompletedA Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 27 kg/m2 or more.NCT06077864·Birmingham, Alabama and 539 others

CompletedPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareUnderstudied drugs will be administered to children per standard of care as prescribed by their treating caregiver and only biological sample collection during the time of drug…NCT01431326·Anchorage, Alaska and 51 others

CompletedEMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death versus placebo on top of standard of care in…NCT03594110·Huntsville, Alabama and 239 others

CompletedHead to Head Study Against Sevelamer HydrochlorideTo compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline.NCT00441545·Mesa, Arizona and 43 others

CompletedFolic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)The purpose of this randomized clinical trial is to determine if lowering homocysteine levels in renal transplant recipients with a multivitamin will reduce the occurrence of…NCT00064753·Birmingham, Alabama and 29 others

CompletedA Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskThe main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at…NCT05803421·Daphne, Alabama and 357 others

CompletedA Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in BloodTreatment with growth hormone (GH; a hormone made by the body that stimulates growth) has been shown to be helpful in treating children with chronic kidney disease who fail to…NCT00212758·Loma Linda, California and 7 others

RecruitingFerric Citrate and Chronic Kidney Disease in ChildrenWe will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23…NCT04741646·Los Angeles, California and 19 others

CompletedA Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIXThis multi-center, open-label Phase 2 trial will study the safety, tolerability, and efficacy of bardoxolone methyl in qualified patients with the following rare chronic kidney…NCT03366337·Birmingham, Alabama and 29 others

TerminatedEffects of Ergocalciferol on Erythropoetin Stimulating Agent DoseHypothesis: The supplementation of Ergocalciferol (Vitamin D2) to those with Vitamin D deficiency in the Chronic Kidney Disease population requiring recombinant human…NCT01263028·Los Angeles, California

CompletedDialysis Clinical Outcomes Revisited (DCOR) TrialThis is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients.NCT00324571·Gadsden, Alabama and 72 others

CompletedA 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on DialysisThis is up to a 58 week study comparing ferric citrate to active control for 52 weeks in ESRD dialysis patients, and subsequently comparing ferric citrate to placebo for 4 weeks.NCT01191255·Tempe, Arizona and 55 others

CompletedPhase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance DialysisOBJECTIVES: I. Evaluate the separate and combined skeletal effects of recombinant human growth hormone (GH) and calcitriol in patients with adynamic renal osteodystrophy.NCT00004340·Los Angeles, California

CompletedSafety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney…NCT00048516·Los Angeles, California and 17 others

TerminatedEvaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on HemodialysisTo evaluate the survival benefit associated with Zemplar therapy as compared to Calcijex for the treatment of secondary hyperparathyroidism in subjects with Stage V chronic kidney…NCT00062699·Tuscaloosa, Alabama and 59 others

CompletedAnit-Inflammatory and Anti-Oxidative Nutrition in Dialysis PatientsStudy of efficiency and safety of oral nutritional supplements with anti-inflammatory and antioxidative properties combined with an appetite stimulant with anti-inflammatory…NCT00561093·Irvine, California and 1 other

RecruitingA Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisThis is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.NCT03633708·Los Angeles, California and 42 others

CompletedTacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE ScoreThe TEAMMATE Trial will enroll 210 pediatric heart transplant patients from 25 centers at 6 months post-transplant and follow each patient for 2.5 years.NCT03386539·Birmingham, Alabama and 24 others

Page 1 of 2Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia